trial

Recovery Group Pilot

NCTId NCT00522613
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 50 (actual)
Sponsored by Kaiser Permanente
Primary completion 2006-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2005-07
Primary completion
2006-12
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Recovery Group Project

Sponsors

Kaiser PermanenteLead Sponsor
Portland State UniversityCollaborator
University of South FloridaCollaborator

Investigators

1
Carla A. Green, PhD, MPHPrincipal Investigator

Sites

1 total
Portland, United States

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2006-12
Status
COMPLETED
relationships
The graph out of here
drug
Recovery Group Project
drug
lead_sponsor
Kaiser Permanente
company
collaborator
Portland State University
company
University of South Florida
company
indication
Bipolar Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Carla A. Green, PhD, MPH
person